Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France

NCT00681369 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00681369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00681369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2007
Completion date
June 30, 2007
Enrollment
217 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer